International angiology : a journal of the International Union of Angiology · 2013
Endovascular treatment of descending thoracic aortic disease. A single center experience.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lange C, Aasland J, Ødegård A, Hatlinghus S, Winnerkvist A, Mattsson E, Myhre H O
Аннотация
AIM: Aim of the study was to assess if endovascular treatment is a feasible alternative in patients with descending thoracic aortic disease.
METHODS: Seventy-three patients were admitted for stent-grafting of descending thoracic aortic disease during the period 1997-2008. The majority of the patients had aneurysm (35) or type B dissection (21), but also traumas, penetrating ulcers and other conditions were treated. Sixteen (22%) were unfit for open surgery. Thirty-four (47%) of the patients were symptomatic and 18 had rupture. The primary technical success rate was 96%.
RESULTS: Early mortality (<30 days) for the whole group was 3%. Early endoleak (<30 days) was identified in 11 patients (15%) of whom 4 (5%) had a secondary procedure. In addition, two trauma patients required insertion of a new stent-graft due to stent-graft collapse. Two patients had stroke, one had paraplegia and two paraparesis. Mean follow-up was 3.1 years (range 0-12 years). Late endoleak (>30 days) was identified in 5 patients (7%) treated by 6 secondary procedures. One patient (1.7%) had an explant. Two patients have had extensions of endografts due to increasing diameter of the aorta at the distal end of the stent-graft.
CONCLUSION: Endovascular treatment seems to be a viable alternative in patients with descending thoracic aortic disease.
METHODS: Seventy-three patients were admitted for stent-grafting of descending thoracic aortic disease during the period 1997-2008. The majority of the patients had aneurysm (35) or type B dissection (21), but also traumas, penetrating ulcers and other conditions were treated. Sixteen (22%) were unfit for open surgery. Thirty-four (47%) of the patients were symptomatic and 18 had rupture. The primary technical success rate was 96%.
RESULTS: Early mortality (<30 days) for the whole group was 3%. Early endoleak (<30 days) was identified in 11 patients (15%) of whom 4 (5%) had a secondary procedure. In addition, two trauma patients required insertion of a new stent-graft due to stent-graft collapse. Two patients had stroke, one had paraplegia and two paraparesis. Mean follow-up was 3.1 years (range 0-12 years). Late endoleak (>30 days) was identified in 5 patients (7%) treated by 6 secondary procedures. One patient (1.7%) had an explant. Two patients have had extensions of endografts due to increasing diameter of the aorta at the distal end of the stent-graft.
CONCLUSION: Endovascular treatment seems to be a viable alternative in patients with descending thoracic aortic disease.
Предметные рубрики MeSH
AdolescentAdultAgedAged, 80 and overAortic DissectionAorta, ThoracicAortic Aneurysm, ThoracicAortic DiseasesAortic RuptureBlood Vessel Prosthesis ImplantationDevice RemovalEndoleakEndovascular ProceduresFeasibility StudiesFemaleHumansKaplan-Meier EstimateMaleMiddle AgedNorwayParaplegiaProsthesis FailureReoperationStrokeTime FactorsTreatment OutcomeUlcerYoung Adult